Diana J Wallin1, Ivan Tkac2, Sara Stucker3, Kathleen M Ennis3, Martha Sola-Visner4, Raghavendra Rao1, Michael K Georgieff1. 1. 1] Graduate Program in Neuroscience, University of Minnesota, Minneapolis, Minnesota [2] Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota. 2. Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, Minnesota. 3. Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota. 4. Division of Newborn Medicine, Boston Children's Hospital and Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Abstract
BACKGROUND: Phlebotomy-induced anemia (PIA) is common in preterm infants. The hippocampus undergoes rapid differentiation during late fetal/early neonatal life and relies on adequate oxygen and iron to support oxidative metabolism necessary for development. Anemia shortchanges these two critical substrates, potentially altering hippocampal development and function. METHODS: PIA (hematocrit <25%) was induced in neonatal mice pups from postnatal day (P)3 to P14. Neurochemical concentrations in the hippocampus were determined using in vivo (1)H NMR spectroscopy at 9.4T and compared with control animals at P14. Gene expression was assessed using quantitative real-time polymerase chain reaction (qRT-PCR). RESULTS: PIA decreased brain iron concentration, increased hippocampal lactate and creatine concentrations, and decreased phosphoethanolamine (PE) concentration and the phosphocreatine/creatine ratio. Hippocampal transferrin receptor (Tfrc) gene expression was increased, while the expression of calcium/calmodulin-dependent protein kinase type IIα (CamKIIα) was decreased in PIA mice. CONCLUSION: This clinically relevant model of neonatal anemia alters hippocampal energy and phospholipid metabolism and gene expression during a critical developmental period. Low target hematocrits for preterm neonates in the neonatal intensive care unit (NICU) may have potential adverse neural implications.
BACKGROUND: Phlebotomy-induced anemia (PIA) is common in preterm infants. The hippocampus undergoes rapid differentiation during late fetal/early neonatal life and relies on adequate oxygen and iron to support oxidative metabolism necessary for development. Anemia shortchanges these two critical substrates, potentially altering hippocampal development and function. METHODS:PIA (hematocrit <25%) was induced in neonatal mice pups from postnatal day (P)3 to P14. Neurochemical concentrations in the hippocampus were determined using in vivo (1)H NMR spectroscopy at 9.4T and compared with control animals at P14. Gene expression was assessed using quantitative real-time polymerase chain reaction (qRT-PCR). RESULTS:PIA decreased brain iron concentration, increased hippocampal lactate and creatine concentrations, and decreased phosphoethanolamine (PE) concentration and the phosphocreatine/creatine ratio. Hippocampal transferrin receptor (Tfrc) gene expression was increased, while the expression of calcium/calmodulin-dependent protein kinase type IIα (CamKIIα) was decreased in PIAmice. CONCLUSION: This clinically relevant model of neonatal anemia alters hippocampal energy and phospholipid metabolism and gene expression during a critical developmental period. Low target hematocrits for preterm neonates in the neonatal intensive care unit (NICU) may have potential adverse neural implications.
Authors: Connie M Arthur; Demet Nalbant; Henry A Feldman; Bejan J Saeedi; Jason Matthews; Brian S Robinson; Nourine A Kamili; Ashley Bennett; Gretchen A Cress; Martha Sola-Visner; Rheinallt M Jones; M Bridget Zimmerman; Andrew S Neish; Ravi M Patel; Peggy Nopoulos; Michael K Georgieff; John D Roback; John A Widness; Cassandra D Josephson; Sean R Stowell Journal: Transfusion Date: 2019-03-21 Impact factor: 3.157
Authors: Sean Lynch; Christine M Pfeiffer; Michael K Georgieff; Gary Brittenham; Susan Fairweather-Tait; Richard F Hurrell; Harry J McArdle; Daniel J Raiten Journal: J Nutr Date: 2018-06-01 Impact factor: 4.798
Authors: Amanda Barks; Montana M Beeson; Timothy C Hallstrom; Michael K Georgieff; Phu V Tran Journal: Dev Neurosci Date: 2022-01-11 Impact factor: 2.984
Authors: Raghavendra Rao; Kathleen Ennis; Gabriele R Lubach; Eric F Lock; Michael K Georgieff; Christopher L Coe Journal: Nutr Neurosci Date: 2016-08-06 Impact factor: 4.994
Authors: Diana J Wallin; Tara G Zamora; Michelle Alexander; Kathleen M Ennis; Phu V Tran; Michael K Georgieff Journal: Pediatr Res Date: 2017-05-31 Impact factor: 3.756
Authors: Tatyana M Matveeva; Garima Singh; Tate A Gisslen; Jonathan C Gewirtz; Michael K Georgieff Journal: Brain Behav Date: 2021-02-19 Impact factor: 2.708